Convince Hemodiafiltration Dialysis Study



It was agreed that any research that CONVINCE generates is based on a prior consensus of all members of the CONVINCE Scientific Committee. 


Liegl G, Fischer FH, Woodward M, Török M, Strippoli GFM, Hegbrant J, Davenport A, Cromm K, Canaud B, Bots ML, Blankestijn PJ, Barth C, Fischer KI, Rose M; CONVINCE Scientific Committee. Physical Performance tasks were lilnked to the PROMIS physical function metric in patients undergoing hemodialysisJ. Clin. Epidemiol. 2023 Apr 25:S0895-4356(23)00092-6. doi: 10.1016/j.clinepi.2023.04.007. Online ahead of print. 

Liegl,Gregor, Fischer,Felix, Blankestijn,Peter, Cromm,Krister, Bots,Michiel, and Rose,Matthias on behalf of the CONVINCE Scientific Committee. Can patient-reported and performance outcome measures be used to assess a common construct of physical function?  Presentation at the 29th Annual Conference ISOQOL, 2022. 

van Kruijsdijk,Rob C M, Vernooij,Robin W M, Bots,Michiel L, Peters,Sanne A E,   Dorresteijn,Jannick A N,  Visseren,Frank L J, Blankestijn,Peter J,  Debray,Thomas P A, The HDF Pooling Project investigators. (2022) Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect prediction, Clinical Kidney Journal 2022; 15(10); 1924-1931. https://doi.org/10.1093/ckj/sfac153

Vernooij, R.W.M., Bots, M.L., Strippoli, G.F.M., Canaud, B., Cromm, K., Woodward, M., Blankestijn, P.J. (2022) CONVINCE in the context of existing evidence on haemodiafiltration Nephrol Dial Transplant 2022 37(6): 1006-1013.  doi: 10.1093/ndt/gfac019

Davenport, Andrew.  Comparison Between the Physical Performance Test and the Clinical Fraialty Score in Adult Patients with Chronic Kidney Disease Treated by Haeamodialysis.  Gerontol Geriatr Med. 2022  Mar 28;8:23337214221085875. doi: 10.1177/23337214221085875 eCollection 2022 Jan-Dec. 

Blankestijn, P.J., Fischer, K.I., Barth, C., Cromm, K., Canaud, B., Davenport, A., ...Rose, M. (2020). Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol. BMJ OPEN, 10 (2), doi:10.1136/bmjopen-2019-033228

Kathrin I. Fischer, Peter J. Blankestijn, Krister Cromm, Michiel L. Bots, Claudia Barth, Bernard Canaud, Jörgen Hegbrant, Giovanni Strippoli, Andrew Davenport, Mark Woodward, Matthias Rose on behalf of the CONVINCE Consortium.  Assessing the Patient’s Perspective in End-stage Kidney Disease –ADomain-Guided Approach Applied in the CONVINCE Trial. Poster presentation at 26th Annual Conference ISOQOL, 2019. 

Fischer KI, Blankestijn PJ, Cromm K, Bots ML, Barth C, Canaud B, Hegbrant J, Macário F, Marrón B, Török M, Davenport A, Lee MM, Strippoli GFM, Wohn L, Woodward M, Rose M. Assessment of generic and dialysis-related fatigue – Identification of individual trajectories and investigation of ecological validity. Quality of Life Research. 2020;29(S1): S180.  https://doi.org/10.1007/s11136-020-02626-y    link to abstract.  Poster presentation at 27th Annual Conference ISOQOL, 2020.

Blankestijn, P.J., Grooteman, M.P., Nube, M.J. and Bots, M.L. (2018).  Clinical evidence on haemodiafiltration.  Nephrology Dialysis Transplantation 33, iii53-iii58. doi: 10.1093/ndt/gfy218.